• PD 173074: FGFR1 Workflows for ALL Research

  2026-08-26

  PD 173074 connects precise FGFR1 pathway interrogation with practical leukemia, angiogenesis, and cancer-cell workflows. This guide shows how to pair target-engagement assays with MIR9-focused molecular profiling, phenotype measurements, and troubleshooting controls.

• BGJ398 (NVP-BGJ398): Reliable FGFR Assays

  2026-08-26

  This scenario-based guide shows how BGJ398 (NVP-BGJ398), SKU A3014, can help researchers design more interpretable FGFR-dependent viability, proliferation, and cytotoxicity experiments. It connects biochemical selectivity, solvent handling, dose optimization, and vendor-selection criteria to practical oncology research workflows.

• JNJ-26854165: Assay Design for p53 Response

  2026-08-25

  JNJ-26854165 (Serdemetan) can reveal how HDM2 blockade produces growth arrest, apoptosis, and radiosensitization. This guide translates its pharmacology into better-timed, mechanism-aware cancer research assays.

• PTH (1-34): A Translational Probe for Calcium Signaling

  2026-08-25

  Parathyroid hormone (1-34) (human) offers translational researchers a defined, receptor-active way to interrogate calcium homeostasis, bone remodeling, renal signaling, and PTH-linked valvular calcification. This article connects the peptide’s validated pharmacology with CKD research and outlines a disciplined path from receptor assays to disease-relevant models.

• Hydroxytyrosol in Nicotine-Linked Kidney Research

  2026-08-24

  Hydroxytyrosol offers a chemically defined way to examine oxidative stress modulation in nicotine-associated renal injury models. This guide connects its redox biology with receptor- and fibrosis-focused assay design while separating established evidence from testable hypotheses.

• SU 5402: From RTK Mechanism to Translation

  2026-08-24

  A mechanistic and strategic guide to using SU 5402 for receptor tyrosine kinase validation, multiple myeloma research, apoptosis and cell-cycle studies, and carefully bounded exploration in human iPSC-derived sensory neuron models of HSV-1 latency.

• Annexin V-Cy5 Apoptosis Kit in Lysosomal Stress

  2026-08-23

  Learn how the Annexin V-Cy5 Apoptosis Kit supports Annexin V apoptosis detection when lysosomal dysfunction can mimic cellular injury. This article develops an interpretation-first workflow for zebrafish microglia, combining phosphatidylserine biology with orthogonal validation.

• Shh–Fgf Control of Penile Development Across Species

  2026-08-22

  Comparing guinea pig and mouse genital tubercle development, Wang and Zheng show that the timing and expression of Shh, Fgf10, and Fgfr2 track whether a fully open urethral groove forms. Tissue mapping, quantitative PCR, and ex vivo protein or inhibitor perturbations support a species-specific model in which reduced Hedgehog/Fgf signaling accompanies delayed preputial development and groove formation.

• CX-5461 Workflow for RNA Polymerase I Inhibition

  2026-08-22

  Build a practical CX-5461 workflow around Pol I suppression, rRNA depletion, DNA-damage signaling, and orthogonal cell-fate assays. The approach helps distinguish cytostasis, autophagy, senescence, and mitotic catastrophe while supporting rational cisplatin-combination studies.

• TMEM16F in Kupffer Cells Limits Listeria Liver Injury

  2026-08-21

  This Advanced Science study identifies Kupffer-cell TMEM16F as a key determinant of host protection during Listeria monocytogenes infection. By combining cell-type-specific mouse genetics with plasma-membrane injury and liver phenotyping, it connects lipid scrambling and membrane repair to control of inflammation, tissue damage, and hepatic metabolism.

• FGFR3 Inhibition in SLC26A2 Chondrodysplasia

  2026-08-20

  The reference study combines genetic models, chondrocyte assays, and pharmacological intervention to show that excessive FGFR3 signaling contributes to SLC26A2-related skeletal dysplasia in mice. Its results support pathway inhibition as a mechanistically grounded, but still preclinical, strategy for improving chondrocyte differentiation and bone architecture.

• JNJ-26854165: Interpreting p53 Drug Responses

  2026-08-20

  JNJ-26854165 (Serdemetan) is an HDM2-targeting compound whose apparent viability effects can reflect both growth arrest and cell death. This guide applies a response-deconvolution framework to improve assay design, mechanistic interpretation, and radiosensitization studies.

• PMSF in IL-6/STAT3 Protein Assays

  2026-08-19

  Phenylmethanesulfonyl fluoride (PMSF) can improve protein preservation in IL-6/STAT3 and cartilage-inflammation assays, but it is not a universal protease or phosphatase inhibitor. This guide explains how to use PMSF selectively without confusing sample protection with pathway modulation.

• WST-8 Glucose Uptake Assay: Workflow Guide

  2026-08-19

  Build a fast, non-radioactive glucose uptake workflow for hepatocyte, diabetes, and cancer metabolism models. This guide connects the WST-8 readout to the Galectin-1–FIP200 autophagy mechanism and provides practical setup, controls, optimization, and troubleshooting advice.

• AG-221 (Enasidenib) in IDH2-Mutant AML

  2026-08-18

  AG-221, also known as Enasidenib, is a selective mutant IDH2 inhibitor for acute myeloid leukemia research. Its central pharmacodynamic effect is 2-hydroxyglutarate reduction, which supports mechanistic studies of differentiation, epigenetic dysregulation, resistance, and metabolic dependencies.

3607 records 2/241 page Previous Next 12345 下5页 Last page